Search - tctmd.com

Displaying 241 - 260 of 488

Sort: Relevancy | Date

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

L.A. McKeown

November 18, 2021

News Conference News AHA 2021

Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND

Michael O'Riordan

November 17, 2021

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

News Conference News AHA 2021

Village-Level Intervention Nets Big BP Control Gains in Rural China

Todd Neale

November 13, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

Zero CAC Questionable for Ruling Out Obstructive CAD in Young Adults

Michael O'Riordan

November 02, 2021

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

L.A. McKeown

November 01, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Daily News

Stimulants Linked to Early Risk of CV Events in Elderly

Michael O'Riordan

October 25, 2021

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

October 15, 2021

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

L.A. McKeown

October 14, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

Advertisement

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

British Medical Groups Express Concern About Inclisiran Rollout

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Village-Level Intervention Nets Big BP Control Gains in Rural China

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Zero CAC Questionable for Ruling Out Obstructive CAD in Young Adults

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

November 2021 News Roundup

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Stimulants Linked to Early Risk of CV Events in Elderly

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

FDA Issues New Guidance on Sodium Targets for Food Industry

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Diabetes Progression in Statin-Treated Patients: VA Data

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content